Centinel Spine Completes Enrollment in 2-Level prodisc Trial

Centinel Spine prodisc-C VIVO and prodisc-C SK

Centinel Spine completed enrollment in an Investigational Device Exemption (IDE) study evaluating the company’s prodisc C Vivo and prodisc C SK cervical Total Disc Replacement. This is reportedly the first IDE trial allowing surgeons to select from two different TDR control devices to treat each surgical level individually.

The prospective,...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us